Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis
Sponsor: Nanfang Hospital, Southern Medical University
Summary
The goal of this intervention clinical trial is to learn about the protection of isomaltooligosaccharides (IMO) on intestinal bacterial translocation in patients with liver cirrhosis. The main question is to answer the changes of LPS after adminstration of IMO.
Official title: Effect of Isomaltooligosaccharides on Intestinal Bacterial Translocation in Patients With Liver Cirrhosis: a Single-center, Single-arm Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2023-11-25
Completion Date
2024-07-01
Last Updated
2024-04-12
Healthy Volunteers
No
Conditions
Interventions
Isomaltooligosaccharides (IMO)
Patients will still receive standard treatment, including medicine and other invasive treatment.
Locations (1)
Nanfang Hospital
Guangzhou, Guangdong, China